Stuttgart
06.02.26 | 21:56
0,001 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,025 | 07.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Episurf Medical AB: Year-end Report 1 January - 31 December 2025 | 56 | GlobeNewswire (Europe) | Significant company transformation through the purchase of real estate and continued progress in the medical device business
"We have taken significant steps forward in 2025. For the fourth quarter... ► Artikel lesen | |
| 26.01. | Episurf Medical AB: Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo | 131 | GlobeNewswire (Europe) | Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 26 January 2026, entered into an agreement regarding the acquisition of a property portfolio consisting of residential... ► Artikel lesen | |
| 08.01. | Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change | 7 | Cision News | ||
| 08.01. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
| 30.12.25 | Episurf Medical AB receives observation status | 228 | GlobeNewswire | Today, December 30, 2025, Episurf Medical AB (the "Company") issued a press release with information that the Company had entered into an agreement regarding the acquisition of all shares in Goldcup... ► Artikel lesen | |
| 30.12.25 | Episurf Medical AB: Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants | 182 | GlobeNewswire (Europe) | The Board of Directors of Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 30 December 2025, entered into an agreement with Goldcup 38657 AB (under name change to Frusipe... ► Artikel lesen | |
| 18.11.25 | Update on Episurf Medical's MTP implant | 3 | Cision News | ||
| 02.11.25 | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 24.10.25 | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 159 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen | |
| 17.10.25 | EPISURF MEDICAL AB: Scientific article on Episealer Knee with up to 10 years' follow-up published | 3 | Cision News | ||
| 12.10.25 | Board Member Resigns from the Board of Episurf Medical | 3 | Cision News | ||
| 30.09.25 | Change in number of shares and votes in Episurf Medical | 2 | Cision News | ||
| 16.09.25 | Episurf Medical AB: New Chief Executive Officer at Episurf Medical | 366 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) today announces that, at his own request, Pål Ryfors will step down as Chief Executive Officer of Episurf Medical. The Board of Directors has appointed Katarina Flodström... ► Artikel lesen | |
| 01.09.25 | EPISURF MEDICAL AB: Episealer included in the Swedish Knee Arthroplasty Register 2025 | 4 | Cision News | ||
| 29.08.25 | Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB | 2 | Cision News | ||
| 28.08.25 | Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue | 1 | Cision News | ||
| 25.08.25 | Episurf Medical announces final outcome of the rights issue | 1 | Cision News | ||
| 22.08.25 | EPISURF MEDICAL AB: Preliminary outcome indicates significantly oversubscribed rights issue | 1 | Cision News | ||
| 20.08.25 | Episurf Medical announces interview with CEO | 1 | Cision News | ||
| 07.08.25 | Listing of units rights and paid subscription units of Episurf Medical AB | 348 | GlobeNewswire | With effect from August 08, 2025, the units rights of Episurf Medical AB will be traded on the list for Equity rights. Trading will continue up until and including August 19, 2025.
Instrument:
Units... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 2,560 | -9,86 % | Imunon stock price target raised to $25 from $14 at H.C. Wainwright | ||
| ELECTROCORE | 4,420 | +3,27 % | electroCore, Inc.: electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million | Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.